Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 4,444,445 | 4,444,445 | 0 | $1.05B | $1.20B | 97.23% | +$154.27M |
| Intellia Therapeutics, Inc.(NTLA) | 3,702,995 | 3,702,995 | 0 | $43.18M | $26.33M | 2.13% | -$16.85M |
| 2seventy Bio, Inc. | 1,254,827 | 1,254,827 | 0 | $3.69M | $6.20M | 0.50% | +$2.51M |
| Adverum Biotechnologies, Inc. | 180,909 | 180,909 | 0 | $844.8K | $790.6K | 0.06% | -$54.3K |
| Adicet Bio, Inc. | 968,183 | 968,183 | 0 | $931.4K | $731.0K | 0.06% | -$200.4K |
| Bluebird Bio, Inc. | 21,000 | 21,000 | 0 | $175.1K | $102.5K | 0.01% | -$72.7K |